<DOC>
	<DOCNO>NCT00002682</DOCNO>
	<brief_summary>RATIONALE : Antibiotic therapy antacid use treat Helicobacter pylorus infection stomach . These treatment may also effect gastric MALT lymphoma stomach . PURPOSE : Phase II trial study effectiveness antibiotic therapy amoxicillin , clarithromycin , tetracycline , metronidazole plus antacids patient MALT lymphoma stomach .</brief_summary>
	<brief_title>Antibiotic Therapy Antacids Patients With Malt Lymphoma Stomach</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate response gastric lymphoma mucosa-associated lymphoid tissue ( MALT ) treatment Helicobacter pylorus infection antibiotic ( amoxicillin , clarithromycin , tetracycline , metronidazole ) gastric acid inhibitor ( omeprazole bismuth subsalicylate ) . II . Correlate response endoscopic tumor grade clinical pathological parameter . III . Assess incidence H. pylori infection patient gastric MALT lymphoma . OUTLINE : All patient treat Regimen A ; receive tetracycline Regimen A switch Regimen B second course ; receive amoxicillin first course receive tetracycline second course . Regimen A : Antibiotic Therapy Gastric Acid Inhibition . Amoxicillin ( Tetracycline penicillin-allergic patient ) ; Clarithromycin ; Bismuth Subsalicylate ; Omeprazole . Regimen B : Antibiotic Therapy Gastric Acid Inhibition . Tetracycline ; Metronidazole , METRO , NSC-50364 ; Bismuth Subsalicylate ; Omeprazole . PROJECTED ACCRUAL : 75 patient enter 3 year .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , B-Cell , Marginal Zone</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Tetracycline</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Bismuth</mesh_term>
	<mesh_term>Bismuth subsalicylate</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Suspected gastric lymphoma document gastric lymphoma mucosaassociated lymphoid tissue ( MALT ) stage IE Gastric MALT lymphoma perigastric lymph node identify endoscopic ultrasound eligible MDACC Houston VA Medical Center No indication expeditious treatment chemotherapy , radiotherapy , surgery base clinical condition , underlie illness , tumor stage PATIENT CHARACTERISTICS : Age : 18 80 Performance status : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No contraindication endoscopy biopsy No pregnant nursing woman Adequate contraception require fertile patient PRIOR CONCURRENT THERAPY : No concurrent chemotherapy radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Antibiotic Treatment</keyword>
	<keyword>Gastric Malt Lymphoma</keyword>
	<keyword>stage I marginal zone lymphoma</keyword>
	<keyword>extranodal marginal zone B-cell lymphoma mucosa-associated lymphoid tissue</keyword>
</DOC>